The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pets NSAIDs Market Research Report 2025
Synopsis
Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body's response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
The global Pets NSAIDs market was valued at US$ 432 million in 2023 and is anticipated to reach US$ 629.1 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.
This report aims to provide a comprehensive presentation of the global market for Pets NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets NSAIDs.
Report Scope
The Pets NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pets NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox
Segment by Type
Injection Type
Oral Type
Others
Segment by Application
Pet Hospital
Pet Shop
Household Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body's response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
The global Pets NSAIDs market was valued at US$ 432 million in 2023 and is anticipated to reach US$ 629.1 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.
This report aims to provide a comprehensive presentation of the global market for Pets NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets NSAIDs.
Report Scope
The Pets NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pets NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox
Segment by Type
Injection Type
Oral Type
Others
Segment by Application
Pet Hospital
Pet Shop
Household Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pets NSAIDs Market Overview
1.1 Product Overview and Scope of Pets NSAIDs
1.2 Pets NSAIDs Segment by Type
1.2.1 Global Pets NSAIDs Market Value Comparison by Type (2024-2030)
1.2.2 Injection Type
1.2.3 Oral Type
1.2.4 Others
1.3 Pets NSAIDs Segment by Application
1.3.1 Global Pets NSAIDs Market Value by Application: (2024-2030)
1.3.2 Pet Hospital
1.3.3 Pet Shop
1.3.4 Household Use
1.4 Global Pets NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Pets NSAIDs Revenue 2019-2030
1.4.2 Global Pets NSAIDs Sales 2019-2030
1.4.3 Global Pets NSAIDs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pets NSAIDs Market Competition by Manufacturers
2.1 Global Pets NSAIDs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pets NSAIDs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pets NSAIDs Average Price by Manufacturers (2019-2024)
2.4 Global Pets NSAIDs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pets NSAIDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pets NSAIDs, Product Type & Application
2.7 Pets NSAIDs Market Competitive Situation and Trends
2.7.1 Pets NSAIDs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pets NSAIDs Players Market Share by Revenue
2.7.3 Global Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pets NSAIDs Retrospective Market Scenario by Region
3.1 Global Pets NSAIDs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pets NSAIDs Global Pets NSAIDs Sales by Region: 2019-2030
3.2.1 Global Pets NSAIDs Sales by Region: 2019-2024
3.2.2 Global Pets NSAIDs Sales by Region: 2025-2030
3.3 Global Pets NSAIDs Global Pets NSAIDs Revenue by Region: 2019-2030
3.3.1 Global Pets NSAIDs Revenue by Region: 2019-2024
3.3.2 Global Pets NSAIDs Revenue by Region: 2025-2030
3.4 North America Pets NSAIDs Market Facts & Figures by Country
3.4.1 North America Pets NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pets NSAIDs Sales by Country (2019-2030)
3.4.3 North America Pets NSAIDs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pets NSAIDs Market Facts & Figures by Country
3.5.1 Europe Pets NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pets NSAIDs Sales by Country (2019-2030)
3.5.3 Europe Pets NSAIDs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets NSAIDs Market Facts & Figures by Country
3.6.1 Asia Pacific Pets NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pets NSAIDs Sales by Country (2019-2030)
3.6.3 Asia Pacific Pets NSAIDs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pets NSAIDs Market Facts & Figures by Country
3.7.1 Latin America Pets NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pets NSAIDs Sales by Country (2019-2030)
3.7.3 Latin America Pets NSAIDs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pets NSAIDs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pets NSAIDs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pets NSAIDs Sales by Type (2019-2030)
4.1.1 Global Pets NSAIDs Sales by Type (2019-2024)
4.1.2 Global Pets NSAIDs Sales by Type (2025-2030)
4.1.3 Global Pets NSAIDs Sales Market Share by Type (2019-2030)
4.2 Global Pets NSAIDs Revenue by Type (2019-2030)
4.2.1 Global Pets NSAIDs Revenue by Type (2019-2024)
4.2.2 Global Pets NSAIDs Revenue by Type (2025-2030)
4.2.3 Global Pets NSAIDs Revenue Market Share by Type (2019-2030)
4.3 Global Pets NSAIDs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pets NSAIDs Sales by Application (2019-2030)
5.1.1 Global Pets NSAIDs Sales by Application (2019-2024)
5.1.2 Global Pets NSAIDs Sales by Application (2025-2030)
5.1.3 Global Pets NSAIDs Sales Market Share by Application (2019-2030)
5.2 Global Pets NSAIDs Revenue by Application (2019-2030)
5.2.1 Global Pets NSAIDs Revenue by Application (2019-2024)
5.2.2 Global Pets NSAIDs Revenue by Application (2025-2030)
5.2.3 Global Pets NSAIDs Revenue Market Share by Application (2019-2030)
5.3 Global Pets NSAIDs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Pets NSAIDs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Pets NSAIDs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 JandJ
6.3.1 JandJ Corporation Information
6.3.2 JandJ Description and Business Overview
6.3.3 JandJ Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 JandJ Pets NSAIDs Product Portfolio
6.3.5 JandJ Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Pets NSAIDs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Septodont
6.5.1 Septodont Corporation Information
6.5.2 Septodont Description and Business Overview
6.5.3 Septodont Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Septodont Pets NSAIDs Product Portfolio
6.5.5 Septodont Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Pets NSAIDs Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 PerioChip
6.6.1 PerioChip Corporation Information
6.6.2 PerioChip Description and Business Overview
6.6.3 PerioChip Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PerioChip Pets NSAIDs Product Portfolio
6.7.5 PerioChip Recent Developments/Updates
6.8 Mobic
6.8.1 Mobic Corporation Information
6.8.2 Mobic Description and Business Overview
6.8.3 Mobic Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mobic Pets NSAIDs Product Portfolio
6.8.5 Mobic Recent Developments/Updates
6.9 Rimadyl
6.9.1 Rimadyl Corporation Information
6.9.2 Rimadyl Description and Business Overview
6.9.3 Rimadyl Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rimadyl Pets NSAIDs Product Portfolio
6.9.5 Rimadyl Recent Developments/Updates
6.10 Vetprofen
6.10.1 Vetprofen Corporation Information
6.10.2 Vetprofen Description and Business Overview
6.10.3 Vetprofen Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vetprofen Pets NSAIDs Product Portfolio
6.10.5 Vetprofen Recent Developments/Updates
6.11 Novox
6.11.1 Novox Corporation Information
6.11.2 Novox Pets NSAIDs Description and Business Overview
6.11.3 Novox Pets NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novox Pets NSAIDs Product Portfolio
6.11.5 Novox Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets NSAIDs Industry Chain Analysis
7.2 Pets NSAIDs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets NSAIDs Production Mode & Process
7.4 Pets NSAIDs Sales and Marketing
7.4.1 Pets NSAIDs Sales Channels
7.4.2 Pets NSAIDs Distributors
7.5 Pets NSAIDs Customers
8 Pets NSAIDs Market Dynamics
8.1 Pets NSAIDs Industry Trends
8.2 Pets NSAIDs Market Drivers
8.3 Pets NSAIDs Market Challenges
8.4 Pets NSAIDs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pets NSAIDs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pets NSAIDs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pets NSAIDs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pets NSAIDs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pets NSAIDs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pets NSAIDs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pets NSAIDs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pets NSAIDs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pets NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pets NSAIDs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pets NSAIDs, Product Type & Application
Table 12. Global Key Manufacturers of Pets NSAIDs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pets NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets NSAIDs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pets NSAIDs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pets NSAIDs Sales by Region (2019-2024) & (K Units)
Table 18. Global Pets NSAIDs Sales Market Share by Region (2019-2024)
Table 19. Global Pets NSAIDs Sales by Region (2025-2030) & (K Units)
Table 20. Global Pets NSAIDs Sales Market Share by Region (2025-2030)
Table 21. Global Pets NSAIDs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pets NSAIDs Revenue Market Share by Region (2019-2024)
Table 23. Global Pets NSAIDs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pets NSAIDs Revenue Market Share by Region (2025-2030)
Table 25. North America Pets NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pets NSAIDs Sales by Country (2019-2024) & (K Units)
Table 27. North America Pets NSAIDs Sales by Country (2025-2030) & (K Units)
Table 28. North America Pets NSAIDs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pets NSAIDs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pets NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pets NSAIDs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pets NSAIDs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pets NSAIDs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pets NSAIDs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pets NSAIDs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pets NSAIDs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pets NSAIDs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pets NSAIDs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pets NSAIDs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pets NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pets NSAIDs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pets NSAIDs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pets NSAIDs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pets NSAIDs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pets NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pets NSAIDs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pets NSAIDs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pets NSAIDs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pets NSAIDs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pets NSAIDs Sales (K Units) by Type (2019-2024)
Table 51. Global Pets NSAIDs Sales (K Units) by Type (2025-2030)
Table 52. Global Pets NSAIDs Sales Market Share by Type (2019-2024)
Table 53. Global Pets NSAIDs Sales Market Share by Type (2025-2030)
Table 54. Global Pets NSAIDs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pets NSAIDs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pets NSAIDs Revenue Market Share by Type (2019-2024)
Table 57. Global Pets NSAIDs Revenue Market Share by Type (2025-2030)
Table 58. Global Pets NSAIDs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pets NSAIDs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pets NSAIDs Sales (K Units) by Application (2019-2024)
Table 61. Global Pets NSAIDs Sales (K Units) by Application (2025-2030)
Table 62. Global Pets NSAIDs Sales Market Share by Application (2019-2024)
Table 63. Global Pets NSAIDs Sales Market Share by Application (2025-2030)
Table 64. Global Pets NSAIDs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pets NSAIDs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pets NSAIDs Revenue Market Share by Application (2019-2024)
Table 67. Global Pets NSAIDs Revenue Market Share by Application (2025-2030)
Table 68. Global Pets NSAIDs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pets NSAIDs Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Pets NSAIDs Product
Table 74. Merck Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Pets NSAIDs Product
Table 79. Bayer Recent Developments/Updates
Table 80. JandJ Corporation Information
Table 81. JandJ Description and Business Overview
Table 82. JandJ Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. JandJ Pets NSAIDs Product
Table 84. JandJ Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GSK Pets NSAIDs Product
Table 89. GSK Recent Developments/Updates
Table 90. Septodont Corporation Information
Table 91. Septodont Description and Business Overview
Table 92. Septodont Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Septodont Pets NSAIDs Product
Table 94. Septodont Recent Developments/Updates
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Roche Pets NSAIDs Product
Table 99. Roche Recent Developments/Updates
Table 100. PerioChip Corporation Information
Table 101. PerioChip Description and Business Overview
Table 102. PerioChip Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. PerioChip Pets NSAIDs Product
Table 104. PerioChip Recent Developments/Updates
Table 105. Mobic Corporation Information
Table 106. Mobic Description and Business Overview
Table 107. Mobic Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Mobic Pets NSAIDs Product
Table 109. Mobic Recent Developments/Updates
Table 110. Rimadyl Corporation Information
Table 111. Rimadyl Description and Business Overview
Table 112. Rimadyl Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Rimadyl Pets NSAIDs Product
Table 114. Rimadyl Recent Developments/Updates
Table 115. Vetprofen Corporation Information
Table 116. Vetprofen Description and Business Overview
Table 117. Vetprofen Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Vetprofen Pets NSAIDs Product
Table 119. Vetprofen Recent Developments/Updates
Table 120. Novox Corporation Information
Table 121. Novox Description and Business Overview
Table 122. Novox Pets NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Novox Pets NSAIDs Product
Table 124. Novox Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Pets NSAIDs Distributors List
Table 128. Pets NSAIDs Customers List
Table 129. Pets NSAIDs Market Trends
Table 130. Pets NSAIDs Market Drivers
Table 131. Pets NSAIDs Market Challenges
Table 132. Pets NSAIDs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pets NSAIDs
Figure 2. Global Pets NSAIDs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pets NSAIDs Market Share by Type in 2023 & 2030
Figure 4. Injection Type Product Picture
Figure 5. Oral Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pets NSAIDs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pets NSAIDs Market Share by Application in 2023 & 2030
Figure 9. Pet Hospital
Figure 10. Pet Shop
Figure 11. Household Use
Figure 12. Global Pets NSAIDs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pets NSAIDs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Pets NSAIDs Sales (2019-2030) & (K Units)
Figure 15. Global Pets NSAIDs Average Price (US$/Unit) & (2019-2030)
Figure 16. Pets NSAIDs Report Years Considered
Figure 17. Pets NSAIDs Sales Share by Manufacturers in 2023
Figure 18. Global Pets NSAIDs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Pets NSAIDs Players: Market Share by Revenue in 2023
Figure 20. Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Pets NSAIDs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Pets NSAIDs Sales Market Share by Country (2019-2030)
Figure 23. North America Pets NSAIDs Revenue Market Share by Country (2019-2030)
Figure 24. United States Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Pets NSAIDs Sales Market Share by Country (2019-2030)
Figure 27. Europe Pets NSAIDs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Pets NSAIDs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Pets NSAIDs Revenue Market Share by Region (2019-2030)
Figure 35. China Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pets NSAIDs Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pets NSAIDs Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pets NSAIDs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pets NSAIDs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Pets NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pets NSAIDs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pets NSAIDs by Type (2019-2030)
Figure 56. Global Pets NSAIDs Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pets NSAIDs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pets NSAIDs by Application (2019-2030)
Figure 59. Global Pets NSAIDs Price (US$/Unit) by Application (2019-2030)
Figure 60. Pets NSAIDs Value Chain
Figure 61. Pets NSAIDs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
